Acumen Pharmaceuticals In... (ABOS)

AI Score

Unlock

1.01

-0.01 (-0.98%)

At close: Apr 24, 2025, 10:38 AM

Acumen Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	35.63M	33.18M	67.95M	46.93M	66.89M	94.92M	77.25M	78M	130.1M	157.54M	111.07M	108.76M	122.16M	135.8M	68.81M	41.41M	43.78M	-6.55M
Short-Term Investments	135.93M	167.16M	192.52M	205.58M	176.64M	120.52M	67.63M	62.41M	47.5M	42.65M	78.84M	80.33M	72.08M	64.16M	n/a	n/a	n/a	13.1M
Long-Term Investments	59.97M	58.55M	20.91M	44.11M	62.55M	67.27M	27.31M	43.42M	15.84M	n/a	20M	27.66M	31.62M	29.91M	n/a	n/a	n/a	n/a
Other Long-Term Assets	379K	406K	476K	558K	454K	378K	391K	195K	151K	429K	344K	79K	14K	13K	2.37M	270K	n/a	-6.55M
Receivables	398K	n/a	106K	189K	225K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	109K	109K	109K	109K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.33M	6.13M	6.12M	2.6M	1.96M	1.88M	1.94M	1.68M	1.42M	499K	980K	1.93M	2.83M	2.29M	1.59M	464K	447K	n/a
Total Current Assets	178.31M	207.63M	266.92M	255.83M	246.62M	218.6M	149.54M	144.03M	180.33M	202.56M	191.05M	192.1M	198.66M	204.91M	70.57M	42.1M	44.43M	6.55M
Property-Plant & Equipment	339K	385K	430K	470K	503K	125K	165K	218K	270K	275K	280K	252K	36K	13K	6K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	184K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	60.69M	59.34M	22M	45.14M	63.51M	67.77M	27.87M	43.83M	16.26M	704K	20.63M	27.99M	31.67M	29.94M	2.37M	270K	n/a	-6.55M
Total Assets	238.99M	266.98M	288.91M	300.97M	310.13M	286.37M	177.41M	187.86M	196.59M	203.26M	211.68M	220.09M	230.33M	234.85M	72.94M	42.37M	44.43M	n/a
Account Payables	5.65M	2.34M	4.21M	3.08M	1.38M	1.36M	2.03M	762K	1.64M	2.08M	1.71M	1.22M	1.09M	382K	2.91M	918K	531K	n/a
Deferred Revenue	n/a	n/a	-125K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	129K	125K	121K	866K	2K	29K	67K	105K	133K	142K	139K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.44M	201K	9.06M	4.12M	6.17M	2.68M	5.08M	6.25M	3.95M	2.81M	2.21M	1.9M	2.96M	310K	1.01M	29.95M	5.5M	n/a
Total Current Liabilities	27.61M	19.91M	15.37M	8.47M	12.97M	6.1M	8.53M	8.78M	7.81M	6.61M	5.13M	3.94M	5.15M	1.49M	4.52M	31.18M	6.37M	n/a
Long-Term Debt	28.45M	29.67M	27.87M	27.6M	27.34M	n/a	n/a	n/a	n/a	n/a	25K	62K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	970K	n/a	1.51M	2.61M	2.56M	n/a	n/a	n/a	n/a	n/a	-25K	-62K	n/a	n/a	174.5M	56.65M	56.65M	n/a
Total Long-Term Liabilities	29.57M	29.86M	29.6M	30.46M	30.18M	n/a	n/a	n/a	n/a	n/a	25K	62K	n/a	n/a	174.5M	56.65M	56.65M	n/a
Total Liabilities	57.18M	49.77M	44.97M	38.93M	43.15M	6.1M	8.53M	8.78M	7.81M	6.61M	5.16M	4M	5.15M	1.49M	179.02M	87.83M	63.02M	n/a
Total Debt	28.73M	29.99M	28.21M	27.97M	28.49M	2K	29K	67K	105K	133K	167K	201K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	6K	6K	6K	6K	6K	6K	4K	4K	4K	4K	4K	4K	4K	4K	n/a	n/a	n/a	n/a
Retained Earnings	-325.13M	-287.97M	-258.21M	-237.67M	-222.8M	-206.3M	-193.34M	-181.73M	-170.43M	-157.56M	-146.85M	-136.7M	-127.57M	-119.22M	-115.32M	-53.96M	-26.96M	n/a
Comprehensive Income	-48K	518K	-164K	-144K	312K	-509K	-646K	-524K	-751K	-965K	-965K	-814K	-231K	-28K	n/a	n/a	n/a	-11.42M
Shareholders Equity	181.82M	217.2M	243.95M	262.03M	266.97M	280.27M	168.87M	179.09M	188.78M	196.65M	206.52M	216.09M	225.18M	233.36M	-106.08M	-45.46M	-18.59M	5.98M
Total Investments	195.9M	225.71M	213.43M	249.69M	239.19M	187.79M	94.94M	105.83M	63.34M	42.65M	98.84M	107.98M	103.69M	94.07M	n/a	n/a	n/a	13.1M